Summary of Research: Aflibercept 8 mg versus Faricimab Treat‑and‑Extend for Diabetic Macular Edema or Neovascular Age‑Related Macular Degeneration: A Bayesian Fixed‑Effect Network Meta‑analysis of Clinical Trials.
Saved in:
| Title: | Summary of Research: Aflibercept 8 mg versus Faricimab Treat‑and‑Extend for Diabetic Macular Edema or Neovascular Age‑Related Macular Degeneration: A Bayesian Fixed‑Effect Network Meta‑analysis of Clinical Trials. |
|---|---|
| Authors: | Friedman, Scott M.1 (AUTHOR) smfriedman83@hotmail.com, Xu, Yingxin2 (AUTHOR), Sherman, Steven2 (AUTHOR), Kuznik, Andreas2 (AUTHOR), Mojebi, Ali3 (AUTHOR), Keeping, Sam3 (AUTHOR), Chan, Keith3 (AUTHOR), Leng, Theodore4 (AUTHOR), Patel, Nimesh A.5,6 (AUTHOR) |
| Source: | Ophthalmology & Therapy. Jun2026, p1-4. 4p. |
| Database: | Academic Search Ultimate |
| ISSN: | 21938245 |
|---|---|
| DOI: | 10.1007/s40123-026-01434-w |
